Prevalence of ICD therapies in primary prevention vs secondary prevention in a sample of patients diagnosed with arrhythmogenic cardiomyopathy

19 May 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: Cardiovascular implantable electronic device in patients with heart failure Implantable Cardioverter-Defibrillator (ICD) HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

ESC 365 is supported by

ESC 365 is supported by